New drug trial aims to reduce need for blood transfusions
NCT ID NCT05891249
Summary
This study is testing a drug called luspatercept to see if it is safe and effective for treating anemia in people with two specific blood disorders: myelodysplastic syndromes (MDS) or beta-thalassemia. The goal is to help patients who currently need regular red blood cell transfusions to reduce their need for them. The study is enrolling 85 participants in India who have not responded well to or cannot take standard anemia treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
New Delhi, National Capital Territory of Delhi, 110029, India
-
Local Institution - 0002
Ahmedabad, Gujarat, 380009, India
-
Local Institution - 0003
Bangalore, 560027, India
-
Local Institution - 0004
Chandigarh, 160012, India
-
Local Institution - 0005
Assam, 781032, India
-
Local Institution - 0006
Hyderabad, 500034, India
-
Local Institution - 0007
Kolkata, West Bengal, 700014, India
-
Local Institution - 0008
Mumbai, 400012, India
-
Local Institution - 0010
Delhi, 110085, India
Conditions
Explore the condition pages connected to this study.